Correction: Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase Inhibitors

Correction: Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase Inhibitors

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559969/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anti-neuraminidase immunity in the combat against influenza
by: Xiaojian Zhang, et al.
Published: (2024-12-01)

The Battle against Influenza: The Role of Neuraminidase Inhibitors in Children
by: Upton Allen
Published: (2000-01-01)

Discovering Influenza Virus Neuraminidase Inhibitors via Computational and Experimental Studies
by: Trung Hai Nguyen, et al.
Published: (2024-11-01)

Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.
by: Natalia A Ilyushina, et al.
Published: (2010-05-01)

The structural basis of protective and nonprotective human monoclonal antibodies targeting the parainfluenza virus type 3 hemagglutinin-neuraminidase
by: Rose J. Miller, et al.
Published: (2024-12-01)

Influenza B virus neuraminidase: a potential target for next-generation vaccines?
by: Thi Hoai Thu Do, et al.
Published: (2024-12-01)

An in-silico approach to target multiple proteins involved in anti-microbial resistance using natural compounds produced by wild mushrooms
by: Gagandeep Singh, et al.
Published: (2024-12-01)

Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma
by: Sasikumar Jalajakumari Soumya, et al.
Published: (2024-09-01)

Identification and Screening of Natural Neuraminidase Inhibitors from Reduning Injection via One-Step High-Performance Liquid Chromatography-Fraction Collector and UHPLC/Q-TOF-MS
by: Lijun An, et al.
Published: (2020-01-01)

Relative fitness of wild-type and phage-resistant pyomelanogenic P. aeruginosa and effects of combinatorial therapy on resistant formation
by: Aarcha Shanmugha Mary, et al.
Published: (2024-11-01)

Protocol to identify small-molecule inhibitors against cancer drug resistance
by: Juan Wei, et al.
Published: (2025-03-01)

Identification of Suitable Natural Inhibitor against Influenza A (H1N1) Neuraminidase Protein by Molecular Docking
by: Maheswata Sahoo, et al.
Published: (2016-09-01)

A model for transmission of partial resistance to anti-malarial drugs
by: Hengki Tasman, et al.
Published: (2009-05-01)

The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial
by: Elena Giudice, et al.
Published: (2024-03-01)

Comparative Antibacterial Activity of Acacia Nilotica Wild. Leaves Extracts Against Multi Drug Resistant Bacteria
by: Manga, S.S., et al.
Published: (2018-06-01)

Screening for anti-fungal resistance in Candida species using chromogenic agar dilution
by: Areej El-Shabrawy, et al.
Published: (2024-05-01)

Synthesis and Biological Evaluation of S-Substituted Perhalo-2-nitrobuta-1,3-dienes as Novel Xanthine Oxidase, Tyrosinase, Elastase, and Neuraminidase Inhibitors
by: Nihal Onul, et al.
Published: (2018-01-01)

Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance
by: Wenjun Meng, et al.
Published: (2024-12-01)

Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases
by: Ami B. Shah, et al.
Published: (2016-07-01)

Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines
by: Guadalupe Cortés, et al.
Published: (2024-11-01)

Colistin Resistance and Management of Drug Resistant Infections
by: Juhi Sharma, et al.
Published: (2022-01-01)

Exosomes-based liquid biopsy: An effective approach for drugs and therapeutics resistance screening in cancer
by: Sidhanti Nyahatkar, et al.
Published: (2024-06-01)

Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells
by: Ceyda Colakoglu Bergel, et al.
Published: (2025-01-01)

Editorial: Ovarian cancer targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more, volume II
by: Zhi-Bin Wang, et al.
Published: (2025-02-01)

Computational design of drug candidates for influenza A virus subtype H1N1 by inhibiting the viral neuraminidase-1 enzyme
by: Tambunan Usman Sumo Friend, et al.
Published: (2014-06-01)

Targeting ferroptosis: a promising strategy to overcome drug resistance in breast cancer
by: Cuixin Peng, et al.
Published: (2024-12-01)

Identification of Mycobacterium tuberculosis and its Drug Resistance by Targeted Nanopore Sequencing Technology
by: Chen Tang, et al.
Published: (2025-02-01)

HDAC3 inhibitors induce drug resistance by promoting IL-17 A production by T cells
by: Hao Chen, et al.
Published: (2024-12-01)

Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study
by: John Youhanna, et al.
Published: (2025-01-01)

Drug resistant epilepsy as the consequence of inadequate control of type 1 diabetes
by: Ewa M. Sokolewicz, et al.
Published: (2024-04-01)

Drug Target Identification and Elucidation of Natural Inhibitors for : An Study
by: Surya Narayan Rath, et al.
Published: (2016-12-01)

Correction: Construction of a camelid VHH yeast two-hybrid library and the selection of VHH against haemagglutinin-neuraminidase protein of the Newcastle disease virus
by: Xiaolong Gao, et al.
Published: (2024-12-01)

Exceptional response to rechallenge of BRAF/MEK inhibitors in patients with primary acquired resistance to targeted therapy
by: B. Ziółkowska, et al.
Published: (2024-01-01)

A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
by: Mengyuan Liu, et al.
Published: (2025-01-01)

Osmotic stressors confer age-dependent resistance to heat stress in wild-type and daf-2 Caenorhabditis elegans
by: Lauren Smith, et al.
Published: (2024-01-01)

Combination Treatment of Resistant Acute Promyelocytic Leukemia Cells with Arsenic Trioxide and Anti-Apoptotic Gene Inhibitors
by: Manuela Giansanti, et al.
Published: (2024-11-01)

Design of a new class of broad-spectrum therapeutics targeted to drug-resistant bacteria
by: Amrutha Surendran, et al.
Published: (2024-12-01)

Optogenetic screening of MCT1 activity implicates a cluster of non-steroidal anti-inflammatory drugs (NSAIDs) as inhibitors of lactate transport.
by: Scott A Wegner, et al.
Published: (2024-01-01)

The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance
by: Mark A. Wainberg
Published: (2012-01-01)

Résistance Anti-Industrielle: Counterprojects
by: Lucien Steil
Published: (2024-11-01)